✨ Your Portfolio is fetched and updated from zerodha.
Small
Market Cap
₹3,542 Cr.
P/E
27.07

Key Ratios

Market cap
Market cap
3,542 Cr
PE
PE
27.07
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
5.61
ROCE (%)
ROCE (%)
6.88
Div Yield (%)
Div Yield (%)
-
Sales
Sales
2,109 Cr
OPM (%)
OPM (%)
11.82 %
Debt to Equity
Debt to Equity
-
About
Unichem Lab is in the Miscellaneous sector with a M.cap of 3542.00 Cr and a PE ratio o… Read more
Low
52W Range
High

Insufficient data

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on Unichem Laboratories Ltd. Business

Unichem Laboratories Limited, a leading pharmaceutical company established in 1962, specializes in manufacturing formulations, APIs, and generic medicines. With over 7 decades of experience, it focuses on supplying affordable medicines globally.

Unichem Lab major competitors are Zota Health Care, Gufic Biosciences, Orchid Pharma, Guj. Themis Biosyn, Sequent Scientific, Panacea Biotec, Indoco Remedies.
Market Cap of Unichem Lab is ₹3,535 Crs.
While the median market cap of its peers are ₹3,663 Crs.

Unichem Lab seems to be less financially stable compared to its competitors.
Altman Z score of Unichem Lab is 3.95 and is ranked 6 out of its 8 competitors.

Company Filing
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material